Announcements Trials

Browse Landscape

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Prostatic Neoplasms 18 Neoplasms 18 Breast Neoplasms 16 Colorectal Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Lung Neoplasms 10 Urinary Bladder Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Hematopoietic and Lymphatic System Neoplasm 6 Hematologic Neoplasms 6 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Triple Negative Breast Neoplasms 4 Leukemia, Myeloid, Acute 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Mouth Neoplasms 3 Hematopoietic and Lymphoid System Neoplasm 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Renal Cell 3 Sarcoma 2 Radiodermatitis 2 Peritoneal Neoplasms 2 Pathologic Complete Response 2 Parotid Neoplasms 2 Motor Activity 2 Melanoma 2 Malignant Solid Neoplasm 2

Interventions

relacorilant 1 pembrolizumab 1 lenvatinib 1 Watchful Waiting 1 Transurethral Resection of Prostate 1 Therapeutic Touch 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Radiotherapy 1 Pregnancy Tests 1 Human Papillomavirus DNA Tests 1 Drug Therapy 1 Colposcopy 1 Brachytherapy 1 Biopsy 1 Bevacizumab 1 Acetic Acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Genital Neoplasms, Female × Standard of Care × Clear all

NCT06089083 2026-01-26

PROOF

University of California, San Francisco

Frailty, Genital Neoplasms, Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡